VIVO Financial Facts

Common share options: -897K
OPERATING INCOME: 8.9M
See Full Income Statement

Other accrued expenses: 2.61M
Buildings and improvements: -61.54M
See Full Balance Sheet

Meridian Bioscience Inc. (VIVO) Earnings

  |   Expand Research on VIVO
Next EPS Date 8/6/21 *Est. EPS Growth Rate N/A
Average EPS % Beat Rate +40.9% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -2.4% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/7/21 Q221 $0.56$0.48 +$0.08$85.3M$84.5M = Details
11/13/20 Q420 $0.19$0.14 +$0.05$64.2M$59.6M = Details
2/7/20 Q120 $0.10$0.06 +$0.04$47.4M$48.7M = Details
11/7/19 Q419 $0.13$0.09 +$0.04$50.8M$50.59M = Details
7/30/19 Q319 $0.16$0.09 +$0.07$48.4M$49.81M = Details
4/30/19 Q219 $0.19$0.16 +$0.03$50.2M$51.74M = Details
1/24/19 Q119 $0.20$0.17 +$0.03$51.5M$53.1M = Details
11/8/18 Q418 $0.20$0.16 +$0.04$53.1M$51.11M = Details